Yüklüyor......
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
BACKGROUND: Ovarian cancer risk in BRCA1 and BRCA2 mutation carriers has been shown to decrease with longer duration of oral contraceptive use. Although the effects of using oral contraceptives in the general population are well established (approximately 50% risk reduction in ovarian cancer), the e...
Kaydedildi:
| Yayımlandı: | Am J Obstet Gynecol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8278569/ https://ncbi.nlm.nih.gov/pubmed/33493488 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2021.01.014 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|